<DOC>
	<DOCNO>NCT02673723</DOCNO>
	<brief_summary>Mortality associate difficult airway anesthesia 30 % . So , urgent find safe effective method intubation . Awake tracheal intubation use retain spontaneous breathe one important measure ensure safety patient difficult airway anesthesia . Sufentanil use provide good analgesia effectively inhibit reaction awake tracheal intubation , however , outstanding problem serious respiratory depression intravenous sufentanil injection . Few study show dezocine kappa opioid antagonist relate mild respiratory depression prevents sufentanil-induced cough general anesthesia induction.It necessary carry large-scale , multi-center , randomize , control clinical study determine whether dezocine prevents sufentanil-induced respiratory depression whether dezocine combine sufentanil safe effective method awake tracheal intubation .</brief_summary>
	<brief_title>The Application Docozine Combined With Sufentanil Awake Tracheal Intubation</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<mesh_term>Dezocine</mesh_term>
	<criteria>1 . Written inform consent； 2 . Selective surgery general anesthesia patients； 3 . Age 1865 yrs； 4 . Anesthesia Society American ( ASA ) Scale I~II； 1 . Mallampatis ⅢⅣ； 2 . Heat rate &lt; 50 beats/minutes； 3 . IIIII Atrioventricular block； 4 . Use alpha agonist antagonist within two weeks； 5 . Use opioid within 24 hours； 6 . Serious heart , liver , kidney disease cerebrovascular disease； 7 . Allergic trial drug anesthesia drug contraindication； 8 . Factors exist affect language communication； 9 . Any respiratory disease； 10 . Unsuccessful intubation 3 time drop intubation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>docozine</keyword>
</DOC>